Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory

Molecular Oncology

Volumn 5, Issue 6, 2011, Pages 555-563

  De Braekeleer, Etienne ^a,b,c   Meyer, Claus ^d   Douet Guilbert, Nathalie ^a,b,c   Basinko, Audrey ^a,b,c   Le Bris, Marie Josée ^c   Morel, Frédéric ^a,b,c   Berthou, Christian ^a,c   Marschalek, Rolf ^d   Férec, Claude ^a,b,c   De Braekeleer, Marc ^a,b,c  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b INSERM   (France)

^c CHU MORVAN   (France)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Acute lymphoblastic leukemia; Acute myeloblastic leukemia; Cytogenetics; FISH; Fusion genes; LDI PCR; MLL

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CLINICAL ARTICLE; ELL GENE; EPS15 GENE; FEMALE; FLNA GENE; GENE FUSION; GENE IDENTIFICATION; GENE INSERTION; GENE TRANSLOCATION; HUMAN; MALE; MLLT3 GENE; MLLT6 GENE; PRIORITY JOURNAL;

EID: 81855201855     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.08.003     Document Type: Article

References (46)

1. Andersson A., Hoglund M., Johansson B., Lassen C., Billstrom R., Garwicz S., Nilsson P.G., Mitelman F., Fioretos T. Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies. Leukemia 2001, 15:1293-1300.
2. Barber K.E., Ford A.M., Harris R.L., Harrison C.J., Moorman A.V. MLL translocations with concurrent 3' deletions: interpretation of FISH results. Genes Chrom. Cancer 2004, 41:266-271.
3. Borkhardt A., Wuchter C., Viehmann S., Pils S., Teigler-Schlegel A., Stanulla M., Zimmermann M., Ludwig W.D., Janka-Schaub C., Schrappe M., Harbott J. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 2002, 16:1685-1690.
4. Burmeister T., Meyer C., Thiel G., Reinhardt R., Thiel E., Marschalek R. A MLL-KIAA0284 fusion gene in a patient with secondary acute myeloid leukemia and t(11;14)(q23;q32). Blood Cells Mol. Dis. 2008, 41:210-214.
5. Byrd J.C., Edenfield J., Shields D.J., Dawson N.A. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J. Clin. Oncol. 1995, 13:1800-1816.
6. Chessells J.M., Harrison C.J., Kempski H., Webb D.K.H., Wheatley K., Hann I.M., Stevens R.F., Harrison G., Gibson B.E. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC childhood Leukaemia working party. Leukemia 2002, 16:776-784.
7. Cimino G., Moir D.T., Canaani O., Williams K., Crist W.M., Katzav S., Cannizzaro L., Lange B., Nowell P.C., Croce C.M., Canaani E. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res. 1991, 51:6712-6714.
8. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003, 17:3029-3035.
9. Daser A., Rabbitts T.H. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin. Cancer Biol. 2005, 15:175-188.
10. De Braekeleer E., Douet-Guilbert N., Morel F., Le Bris M.J., Meyer C., Marschalek R., Férec C., De Braekeleer M. FLNA, a new partner gene fused to MLL in a patient with acute myelomonoblastic leukaemia. Br. J. Haematol. 2009, 146:693-695.
11. De Braekeleer E., Ianotto J.C., Douet-Guilbert N., Meyer C., Morel F., Le Bris M.J., Marschalek R., Berthou C., Férec C., De Braekeleer M. A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene. Blood Cells Mol. Dis. 2009, 42:292-293.
12. De Braekeleer E., Meyer C., Douet-Guilbert N., Morel F., Le Bris M.J., Berthou C., Arnaud B., Marschalek R., Férec C., De Braekeleer M. Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature. Blood Cells Mol. Dis. 2010, 44:268-274.
13. De Braekeleer E., Meyer C., Douet-Guilbert N., Morel F., Le Bris M.J., Marschalek R., Férec C., De Braekeleer M. A complex 1;19;11 translocation involving the MLL gene in a patient with congenital acute monoblastic leukemia identified by molecular and cytogenetic techniques. Ann. Hematol. 2009, 88:795-797.
14. De Braekeleer E., Meyer C., Le Bris M.J., Douet-Guilbert N., Basinko A., Morel F., Berthou C., Marschalek R., Férec C., De Braekeleer M. Identification of a MLL-AF6 fusion gene resulting from a t(6;11)(q27;q23) presenting as a del(11q) in a child with T-cell acute lymphoblastic leukemia. Leuk. Lymphoma 2010, 51:1570-1573.
15. De Braekeleer M., Morel F., Le Bris M.J., Herry A., Douet-Guilbert N. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res. 2005, 25:1931-1944.
16. Douet-Guilbert N., Basinko A., Morel F., Le Bris M.J., Ugo V., Morice P., Berthou C., De Braekeleer M. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions. Ann. Hematol. 2008, 87:537-544.
17. Douet-Guilbert N., Morel F., Le Bris M.J., Sassolas B., Giroux J.D., De Braekeleer M. Rearrangement of MLL in a patient with congenital acute monoblastic leukemia and granulocytic sarcoma associated with a t(1;11)(p36;q23) translocation. Leuk. Lymphoma 2005, 46:143-146.
18. Feng Y., Walsh C.A. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat. Cell. Biol. 2004, 6:1034-1038.
19. Guarguaglini G., Duncan P.I., Stierhof Y.D., Holmstrom T., Duensing S., Nigg E.A. The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles. Mol. Biol. Cell 2005, 16:1095-1107.
20. Harper D.P., Aplan P.D. Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Res. 2008, 68:10024-10027.
21. Harrison C.J., Griffiths M., Moorman F., Schnittger S., Cayuela J.M., Shurtleff S., Gottardi E., Mitterbauer G., Colomer D., Delabesse E., Casteras V., Maroc N. A multicenter evaluation of comprehensive analysis of MLL translocations and fusion gene partners in acute leukemia using the MLL FusionChip device. Cancer Genet. Cytogenet. 2007, 173:17-22.
22. An International System for Human Cytogenetic Nomenclature 2005, ISCN, S. Karger, Basel.
23. Jansen M.W., van Dongen J.J. Efficient and easy detection of MLL-AF4, MLL-AF9 and MLL-ENL fusion gene transcripts by multiplex real-time quantitative RT-PCR in TaqMan and LightCycler. Leukemia 2005, 19:2016-2018.
24. Johansson B., Moorman A.V., Haas O.A., Watmore A.E., Cheung K.L., Swanton S., Secker-Walker L.M., on behalf of the European 11q23 Workshop participants Hematologic malignancies with t(4;11)(q21;q23) - a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. Leukemia 1998, 12:779-787.
25. Johansson B., Moorman A.V., Secker-Walker L.M., on behalf of the European 11q23 Workshop participants Derivative chromosomes of 11q23-translocations in hematologic malignancies. Leukemia 1998, 12:828-833.
26. Jones D.H., Winistorfer S.C. Sequence specific generation of a DNA panhandle permits PCR amplification of unknown flanking DNA. Nucleic Acids Res. 1992, 20:595-600.
27. Kobayashi H., Espinosa R., Thirman M.J., Fernald A.A., Shannon K., Diaz M.O., Le Beau M.M., Rowley J.D. Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization. Genes Chrom. Cancer 1993, 7:204-208.
28. Krivtsov A.V., Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 2007, 7:823-833.
29. Langer T., Metzler M., Reinhardt D., Viehmann S., Borkhardt A., Reichel M., Stanulla M., Schrappe M., Creutzig U., Ritter J., Leis T., Jacobs U., Harbott J., Beck J.D., Rascher W., Repp R. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chrom. Cancer 2003, 36:393-401.
30. Ludwig W.D., Rieder H., Bartram C.R., Heinze B., Schwartz S., Gassman W., Loffler H., Hossfeld D., Heil G., Handt S., Heyll A., Diedrich H., Fischer K., Weiss A., Volkers B., Aydemir U., Fonatsch C., Gokbuget N., Thiel E., Hoelzer D. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 1998, 92:1898-1909.
31. Maroc N., Morel A., Beillard E., de la Chapelle A.L., Fund X., Mozziconacci M.J., Dupont M., Cayuela J.M., Gabert J., Koki A., Fert V., Hermitte F. A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Leukemia 2004, 18:1522-1530.
32. Matutes E., Pickl W.F., van't Veer M., Morilla R., Swansbury J., Strobl H., Attarbaschi A., Hopfinger G., Ashley S., Bene M.C., Porwit A., Orfao A., Lemez P., Schabath R., Ludwig W.D. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patents defined according to the WHO 2008 classification. Blood 2011, 117:3163-3171.
33. Meyer C., Burmeister T., Strehl S., Schneider B., Hubert D., Zach O., Haas O., Klingebiel T., Dingermann T., Marschalek R. Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. Leukemia 2007, 21:588-590.
34. Meyer C., Kowarz E., Hofmann J., Renneville A., Zuna J., Trka J., Ben Abdelali R., MacIntyre E., De Braekeleer E., De Braekeleer M., Delabesse E., de Oliveira M.P., Cave H., Clappier E., van Dongen J.J., Balgobind B.V., van den Heuvel-Eibrink M.M., Beverloo H.B., Panzer-Grumayer R., Teigler-Schlegel A., Harbott J., Kjeldsen E., Schnittger S., Koehl U., Gruhn B., Heidenreich O., Chan L.C., Yip S.F., Krzywinski M., Eckert C., Moricke A., Schrappe M., Alonso C.N., Schafer B.W., Krauter J., Lee D.A., Zur S.U., te K.G., Sutton R., Izraeli S., Trakhtenbrot L., Lo N.L., Tsaur G., Fechina L., Szczepanski T., Strehl S., Ilencikova D., Molkentin M., Burmeister T., Dingermann T., Klingebiel T., Marschalek R. New insights to the MLL recombinome of acute leukemias. Leukemia 2009, 23:1490-1499.
35. Meyer C., Schneider B., Reichel M., Angermueller S., Strehl S., Schnittger S., Schoch C., Jansen M.W., van Dongen J.J., Pieters R., Haas O.A., Dingermann T., Klingebiel T., Marschalek R. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:449-454.
36. Morel F., Le Bris M.J., Douet-Guilbert N., Duchemin J., Herry A., Le Calvez G., Marion V., Berthou C., De Braekeleer M. Insertion of chromosome 11 in chromosome 4 resulting in a 5'MLL-3'AF4 fusion gene in a case of adult acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 2003, 145:74-77.
37. Ochman H., Gerber A.S., Hartl D.L. Genetic applications of an inverse polymerase chain reaction. Genetics 1988, 120:621-623.
38. Ouansafi I., Arabadjief M., Mathew S., Srivastara S., Orazi A. Myeloid sarcoma with t(11;19)(q23;p13.3) (MLL-ELL) in the uterine cervix. Br. J. Haematol. 2011, 153:679.
39. Park K.U., Lee D.S., Lee H.S., Kim C.J., Cho H.I. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia. Am. J. Pathol. 2001, 159:2011-2016.
40. Prasad R., Gu Y., Alder H., Nakamura T., Canaani O., Saito H., Huebner K., Gale R.P., Nowell P.C., Kuriyama K. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res. 1993, 53:5624-5628.
41. Pui C.H., Gaynon P.S., Boyett J.M., Chessells J.M., Baruchel A., Kamps W., Silverman L.B., Biondi A., Harms D.O., Vilmer E., Schrappe M., Camitta B. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002, 359:1909-1915.
42. Reichel M., Gillert E., Angermuller S., Hensel J.P., Heidel F., Lode M., Leis T., Biondi A., Haas O.A., Strehl S., Panzer-Grumayer E.R., Griesinger F., Beck J.D., Greil J., Fey G.H., Uckun F.M., Marschalek R. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 2001, 20:2900-2907.
43. Ribera J.M., Ortega J.J., Oriol A., Granada I., Hernandez-Rivas J.M., Parody R., Bethencourt C., Rivas C., Bastida P., del Potro E., Gonzalez-Valentin M.E., Moreno M.J., Besalduch J., Fernandez-Calvo J., Tormo M., Arias J., Molines A., Sanz M.A., Maldonado J., Milla F., Feliu E., San Miguel J.F. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Haematologica 2002, 87:154-166.
44. Stossel T.P., Condeelis J., Cooley L., Hartwig J.H., Noegel A., Schleicher M., Shapiro S.S. Filamins as integrators of cell mechanics and signalling. Nat. Rev. Mol. Cell. Biol. 2001, 2:138-145.
45. van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Diaz M.G., Malec M., Langerak A.W., San Miguel J.F., Biondi A. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999, 13:1901-1928.
46. Ziemin-van der Poel S., McCabe N.R., Gill H.J., Espinosa R.I., Patel Y., Harden A., Rubinelli P., Smith S.D., LeBeau M.M., Rowley J.D., Diaz M.O. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10735-10739.